- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
M1CK34
SAO
Week ended 21 Aug 2026
Weekly Investor Report
McKesson Corporation · Healthcare · Medical Distribution
Latest close
69.23 BRL
-2.2%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is 1.9% above the Trend Line and sits at 52.1% of its 52-week range. The latest completed week returned -2.2%, after a 4.8% four-week move. The latest news-sentiment score is 55/100. Near-term considerations: volume confirmation is below normal.
Setup score
46
out of 100
Latest Close
69.23 BRL
21 Aug 2026
1W Return
-2.2%
latest completed week
4W Return
4.8%
short-term follow-through
12W Return
9.9%
quarterly tape
Trend Breadth
50.0%
26 of 52 weeks active
Volume Ratio
0.1x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Latest weekly return ranks in the weaker part of its sector group.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-2.2%
Latest completed week; four-week move 4.8%.
Indicator stack
28/71
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
55/100
27 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 1.9% above the Trend Line and sits at 52.1% of its 52-week range. The latest completed week returned -2.2%, after a 4.8% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.1x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
14 Aug
21 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.3512-week average 0.16
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure6/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership2/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.35Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 4.8% over four weeks, 9.9% over 12 weeks, and 15.3% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year26
Trend breadth50.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.80Latest activity-pressure read.
Pressure change80.0%Four-week change in activity pressure.
Leadership0.05Latest relative-leadership reading.
RS change100.7%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment55/100
Weighted news tone is neutral across 27 relevant articles.
13 positive · 12 neutral · 2 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-15.3%Distance below the 52-week high.
13-week volatility2.6%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
27 Feb
27 Mar
24 Apr
22 May
19 Jun
17 Jul
21 Aug
Weeks higher11 of 2614 weeks finished lower.
Best week+7.1%Week of 15 May.
Worst week-10.0%Week of 8 May.
Latest week-2.2%Week of 21 Aug.
Shape of recent returns
Strong gains3
Modest gains8
Flat weeks1
Modest losses11
Sharp losses3
Recent vol2.6%13-week weekly-return volatility.
Base vol3.8%52-week weekly-return volatility.
Up/down split27/20Count of positive and negative weeks in the 52-week window.
Average skew2.9% / -3.1%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorBR Healthcare
4-week rank42 / 82
Group average8.3%
Trend breadth39.0%
Trend39.0%active weekly trend signals
MD74.4%positive activity pressure
RS52.4%positive relative leadership
Four-week leaders
IndustryBR Medical Distribution
4-week rank2 / 4
Group average5.8%
Trend breadth25.0%
Trend25.0%active weekly trend signals
MD75.0%positive activity pressure
RS50.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape43/100
Trend, activity pressure, participation, and risk combine to a 43/100 tape read.
Indicator analysis28/100Latest 12-week confirmation: trend 0/12, activity pressure 6/12, relative leadership 2/12.
Activity pressure 0.35; No reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment55/100Weighted news tone is neutral across 27 relevant articles.
McKesson to Buy Precision Medicine in $2.25 Billion Deal Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 21 Aug 2026 | 69.23 BRL | -2.2% | 67.97 BRL | 54.69 BRL | 0.80 | 0.05 | 795 | Off |
| 14 Aug 2026 | 70.78 BRL | 1.8% | 67.91 BRL | 54.46 BRL | 0.72 | 4.65 | 3.6K | Off |
| 7 Aug 2026 | 69.51 BRL | 2.3% | 67.89 BRL | 54.22 BRL | 0.79 | -0.63 | 11.3K | Off |
| 31 Jul 2026 | 67.97 BRL | 2.9% | 67.86 BRL | 53.98 BRL | 0.62 | -6.00 | 5.5K | Off |
| 24 Jul 2026 | 66.06 BRL | -2.7% | 67.98 BRL | 53.75 BRL | 0.44 | -6.93 | 1.1K | Off |
| 17 Jul 2026 | 67.88 BRL | 6.0% | 68.16 BRL | 53.52 BRL | 0.09 | -4.56 | 16.4K | Off |
| 10 Jul 2026 | 64.07 BRL | 0.2% | 68.26 BRL | 53.28 BRL | -0.39 | -12.32 | 11.3K | Off |
| 3 Jul 2026 | 63.95 BRL | 3.8% | 68.42 BRL | 53.07 BRL | -0.77 | -11.04 | 6.3K | Off |
| 26 Jun 2026 | 61.63 BRL | 0.7% | 68.58 BRL | 52.86 BRL | -0.95 | -14.01 | 1.5K | Off |
| 19 Jun 2026 | 61.19 BRL | -1.6% | 68.99 BRL | 52.66 BRL | -0.94 | -12.63 | 4.8K | Off |
| 12 Jun 2026 | 62.16 BRL | -0.5% | 69.35 BRL | 52.46 BRL | -0.91 | -12.94 | 1.2K | Off |
| 5 Jun 2026 | 62.47 BRL | -0.9% | 69.61 BRL | 52.26 BRL | -0.84 | -11.79 | 6.8K | Off |
| 29 May 2026 | 63.01 BRL | 5.1% | 69.90 BRL | 52.05 BRL | -0.90 | -13.79 | 3.4K | Off |
| 22 May 2026 | 59.99 BRL | -0.6% | 70.07 BRL | 51.85 BRL | -0.94 | -19.40 | 10.9K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.